Neonates and infants have lower levels of plasma proteins such as albumin and alpha-1-acid glycoprotein. This reduced protein concentration can lead to higher free drug levels, potentially increasing the risk of drug toxicity. With age, protein levels gradually reach adult values, altering the drug binding dynamics.
